| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.486 | 10.524 | 12.260 | 34.433 | 20.842 | 8.785 | 22.900 | 20.816 | 30.420 | 21.148 |
| Total Income - EUR | 9.533 | 10.636 | 12.263 | 34.433 | 20.842 | 10.003 | 22.903 | 20.857 | 30.420 | 21.148 |
| Total Expenses - EUR | 18.280 | 16.156 | 17.935 | 24.539 | 26.618 | 20.394 | 23.422 | 22.243 | 24.915 | 18.579 |
| Gross Profit/Loss - EUR | -8.747 | -5.520 | -5.672 | 9.893 | -5.776 | -10.391 | -519 | -1.386 | 5.506 | 2.569 |
| Net Profit/Loss - EUR | -9.033 | -5.626 | -5.895 | 9.549 | -5.985 | -10.472 | -557 | -1.595 | 5.121 | 1.935 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Dolimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 450 | 1.122 | 785 | 1.100 | 969 | 892 | 1.366 | 4.848 | 4.055 | 2.657 |
| Current Assets | 6.497 | 1.820 | 2.723 | 4.460 | 3.836 | 4.454 | 3.877 | 4.413 | 4.341 | 5.765 |
| Inventories | 2.243 | 972 | 1.630 | 2.225 | 3.093 | 3.395 | 3.714 | 4.322 | 3.059 | 3.042 |
| Receivables | 0 | 28 | 0 | 0 | 0 | 0 | 96 | 0 | 0 | 0 |
| Cash | 4.253 | 820 | 1.093 | 2.234 | 743 | 1.059 | 68 | 92 | 1.283 | 2.723 |
| Shareholders Funds | 5.927 | 240 | -5.659 | 3.994 | -2.068 | -12.501 | -12.780 | -14.415 | -9.250 | -7.264 |
| Social Capital | 45 | 45 | 44 | 43 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debts | 1.020 | 2.702 | 9.167 | 1.565 | 6.873 | 17.847 | 18.024 | 23.676 | 17.646 | 15.685 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Dolimed S.r.l.